How to make a better T cell: in vivo CRISPR screens have some answers
2021-01-07MatteoVilla
四川生理科学杂志 2021年2期
Matteo Villa
Understanding what regulates CD8+ T cell responses is key to effectively harnessing these cells in human disease. In this issue of Cell, Huang et al. and Chen et al. use in vivo CRISPR screens to discover novel regulators of CD8+ T cell immunity to engineer a more efficacious response against cancer and infections.
杂志排行
四川生理科学杂志的其它文章
- Auto-aggressive CXCR6 + CD8 T cells cause liver immune pathology in NASH
- The molecular assembly of the marsupial γμ T cell receptor defines a third T cell lineage
- Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
- Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults
- The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia